Literature DB >> 11805381

Clinical benefit and approach of ultrafiltration in acute heart failure.

A Sharma1, D D Hermann, R L Mehta.   

Abstract

Because of the increasing incidence of acute heart failure admissions to critical care units, nephrologists have been asked to become more involved in the management of these patients. Renal dysfunction is a major element in impeding clinical recovery. In acute heart failure, renal function is often abnormal. The judicious application of ultrafiltration techniques may represent an efficacious adjunct to present conventional practice. In patients with refractory congestive heart failure, the ability to provide continuous, daily, large volume removal not only improves volume status but also the clinical symptoms of the decompensated patient. A thorough literature review supports the premise that starting hemofiltration is an appropriate alternative for difficult and unstable cardiac patients. An optimal strategy utilizing continuous renal replacement therapy can dramatically improve the patient's clinical condition, mitigate the neurohumoral stimulation, increase urinary output and promote absorption of excessive extravascular fluid. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11805381     DOI: 10.1159/000047398

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  4 in total

Review 1.  Ultrafiltration in decompensated heart failure.

Authors:  Brian E Jaski; David Miller
Journal:  Curr Heart Fail Rep       Date:  2005-09

Review 2.  Venous congestion, endothelial and neurohormonal activation in acute decompensated heart failure: cause or effect?

Authors:  Paolo C Colombo; Amanda C Doran; Duygu Onat; Ka Yuk Wong; Myra Ahmad; Hani N Sabbah; Ryan T Demmer
Journal:  Curr Heart Fail Rep       Date:  2015-06

Review 3.  Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.

Authors:  J Malcom O Arnold; Jonathan G Howlett; Paul Dorian; Anique Ducharme; Nadia Giannetti; Haissam Haddad; George A Heckman; Andrew Ignaszewski; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; John D Parker; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Vivek Rao; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2007-01       Impact factor: 5.223

Review 4.  Cardiorenal syndrome: ultrafiltration therapy for heart failure--trials and tribulations.

Authors:  Amir Kazory
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-30       Impact factor: 8.237

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.